{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T08:10:20Z","timestamp":1770538220898,"version":"3.49.0"},"reference-count":400,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1097\/01.mjt.0000208272.42379.aa","type":"journal-article","created":{"date-parts":[[2007,2,15]],"date-time":"2007-02-15T09:06:35Z","timestamp":1171530395000},"page":"63-105","source":"Crossref","is-referenced-by-count":24,"title":["Recurrent Headache as the Main Symptom of Acquired Cerebral Toxoplasmosis in Nonhuman Immunodeficiency Virus-infected Subjects With no Lymphadenopathy"],"prefix":"10.1097","volume":"14","author":[{"given":"Joseph","family":"Prandota","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-11-20210202","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1128\/CMR.11.4.569","article-title":"Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection.","volume":"11","author":"Denkers","year":"1998","journal-title":"Clin Microbiol Rev"},{"key":"R4-11-20210202","first-page":"133","article-title":"Toxoplasmosis in southeastern Brazil: an alarming situation of highly endemic acquired and congenital infection.","volume":"31","author":"Bahia-Oliveira","year":"2001","journal-title":"Int J Parasitol"},{"key":"R6-11-20210202","first-page":"25","article-title":"Seroepidemiology of toxoplasmosis in the Lublin region.","volume":"8","author":"Sroka","year":"2001","journal-title":"Ann Agric Environ Med"},{"key":"R7-11-20210202","first-page":"182","article-title":"Central nervous system toxoplasmosis in acquired immunodeficiency syndrome.","volume":"47","author":"Mathew","year":"1999","journal-title":"Neurol India"},{"key":"R8-11-20210202","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0149-2918(96)80059-2","article-title":"Treatment regimens for patients with toxoplasmic encephalitis.","volume":"18","author":"Fung","year":"1996","journal-title":"Clin Ther"},{"key":"R9-11-20210202","first-page":"160","article-title":"Toxoplasmosis in HIV\/AIDS patients: a current situation.","volume":"57","author":"Nissapatorn","year":"2004","journal-title":"Jpn J Infect Dis"},{"key":"R10-11-20210202","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1046\/j.1469-0691.2002.00485.x","article-title":"Toxoplasma gondii: transmission, diagnosis and prevention.","volume":"8","author":"Hill","year":"2002","journal-title":"Clin Microbiol Infect"},{"key":"R11-11-20210202","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/bmj.309.6957.765","article-title":"Prevalence of headache and migraine in school children.","volume":"309","author":"Abu-Arafeh","year":"1994","journal-title":"BMJ"},{"key":"R12-11-20210202","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/00023210-199810020-00003","article-title":"Migraine in children. Guidelines for treatment.","volume":"10","author":"Hamalainen","year":"1998","journal-title":"CNS Drugs"},{"key":"R14-11-20210202","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1046\/j.1468-2982.1992.1204221.x","article-title":"Migraine with aura and migraine without aura: an epidemiological study.","volume":"12","author":"Rasmussen","year":"1992","journal-title":"Cephalalgia"},{"key":"R15-11-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.322.7295.1145","article-title":"Relation between headache in childhood and physical and psychiatric symptoms in adulthood: national birth cohort study.","volume":"322","author":"Fearon","year":"2001","journal-title":"BMJ"},{"key":"R16-11-20210202","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1177\/088307380401900505","article-title":"Assessment of child neurology outpatients with headache, dizziness and fainting.","volume":"19","author":"Emiroglu","year":"2004","journal-title":"J Child Neurol"},{"key":"R17-11-20210202","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/cap.1996.6.153","article-title":"The association between major depression and headache: results of longitudinal epidemiologic study in youth.","volume":"6","author":"Pine","year":"1996","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"R21-11-20210202","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/jemt.1081","article-title":"Neurogenic inflammation in the context of migraine.","volume":"53","author":"Williamson","year":"2001","journal-title":"Microsc Res Technol"},{"key":"R22-11-20210202","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1468-2982.2001.00196.x","article-title":"Migraine and function of the immune system: a meta-analysis of clinical literature published between 1966 and 1999.","volume":"21","author":"Kemper","year":"2001","journal-title":"Cephalalgia"},{"key":"R23-11-20210202","first-page":"313","article-title":"The trigemino-vascular system and migraine.","volume":"40","author":"Buzzi","year":"1992","journal-title":"Pathol Biol (Paris)"},{"key":"R24-11-20210202","first-page":"483","article-title":"Persisting headache as an early symptom of acquired toxoplasmosis not manifested by enlargement of peripheral lymphatic nodes.","volume":"63","author":"Prandota","year":"1988","journal-title":"Pediatria Pol"},{"key":"R25-11-20210202","first-page":"930","article-title":"Persisting headache as an early symptom of acquired toxoplasmosis not manifested by enlargement of peripheral lymph nodes. Further cases.","volume":"5","author":"Prandota","year":"1998","journal-title":"Klinika"},{"key":"R26-11-20210202","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1128\/JCM.11.6.562-568.1980","article-title":"Direct agglutination test for diagnosis of toxoplasma infection: method for increasing sensitivity and specificity.","volume":"11","author":"Desmonts","year":"1980","journal-title":"J Clin Microbiol"},{"key":"R27-11-20210202","first-page":"673","article-title":"Administration of levamisol to children with renal disease exacerbations caused by recurrent respiratory infections.","volume":"44","author":"Prandota","year":"1989","journal-title":"Polski Tygodnik Lek"},{"key":"R28-11-20210202","first-page":"454","article-title":"Immune status and the effect of long-term levamisol therapy on selected immune parameters in children with steroid-sensitive nephrotic syndrome during remission.","volume":"48","author":"Prandota","year":"1993","journal-title":"Polski Tygodnik Lek"},{"key":"R29-11-20210202","first-page":"1095","article-title":"Analysis of the humoral and cellular immunity parameters in children with acquired toxoplasmosis.","volume":"72","author":"Wozniakowska-Gesicka","year":"1997","journal-title":"Pediatria Pol"},{"key":"R30-11-20210202","first-page":"19","article-title":"Interpretation of the results of the serological tests in toxoplasmosis.","volume":"35","author":"Rydzewski","year":"1981","journal-title":"Przegl Epidemiol"},{"key":"R31-11-20210202","first-page":"31","article-title":"Comparative study of the three techniques detecting anti-toxoplasma antibodies of IgM class.","volume":"38","author":"Dzbenski","year":"1986","journal-title":"Med Dosw Mikrobiol"},{"key":"R32-11-20210202","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0019-2791(65)90004-2","article-title":"Immunochemical quantification of antigens by single radial immunodiffusion.","volume":"2","author":"Mancini","year":"1965","journal-title":"Immunochemistry"},{"key":"R34-11-20210202","first-page":"321","article-title":"Modern views on acquired toxoplasmosis of the nervous system.","volume":"37","author":"Rybak","year":"1982","journal-title":"Polski Tygodnik Lek"},{"key":"R35-11-20210202","first-page":"1181","article-title":"Diagnostic criteria in toxoplasmosis.","volume":"39","author":"Dzbenski","year":"1984","journal-title":"Polski Tygodnik Lek"},{"key":"R36-11-20210202","first-page":"935","article-title":"Acquired toxoplasmosis in children manifested bylymph node enlargement.","volume":"37","author":"Barankiewicz","year":"1982","journal-title":"Polski Tygodnik Lek"},{"key":"R37-11-20210202","first-page":"1297","article-title":"Tuberous-nodular form of acquired toxoplasmosis.","volume":"35","author":"Jezyna","year":"1982","journal-title":"Wiad Lek"},{"key":"R38-11-20210202","first-page":"569","article-title":"Cerebral form of acquired toxoplasmosis in a 14-year-old boy.","volume":"58","author":"Lesniarek","year":"1983","journal-title":"Pediatria Pol"},{"key":"R39-11-20210202","first-page":"1083","article-title":"Acquired systemic toxoplasmosis in the light of observed cases.","volume":"37","author":"Mierzejewska","year":"1980","journal-title":"Wiad Lek"},{"key":"R40-11-20210202","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/00006454-199706000-00013","article-title":"Toxoplasmosis of the central nervous system in non-human immunodeficiency virus-infected children: case report and review of the literature.","volume":"16","author":"Khan","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"R41-11-20210202","first-page":"21","article-title":"Diffuse toxoplasmic encephalitis in a non-immunosuppresed patient.","volume":"76","author":"Lescop","year":"1995","journal-title":"J Radiol"},{"key":"R42-11-20210202","first-page":"381","article-title":"Prophylaxis of HIV infection in children after accidental exposure.","volume":"80","author":"Piekarska","year":"2005","journal-title":"Pediatria Pol"},{"issue":"Suppl 4","key":"R44-11-20210202","first-page":"45","article-title":"Neurotoxoplasmosis.","volume":"35","author":"Kociecka","year":"2001","journal-title":"Neur Neurochir Pol"},{"key":"R45-11-20210202","doi-asserted-by":"crossref","first-page":"517","DOI":"10.4269\/ajtmh.1987.36.517","article-title":"Cyst rupture as a pathogenic mechanism of toxoplasmic encephalitis.","volume":"36","author":"Frenke","year":"1987","journal-title":"Am J Trop Med Hyg"},{"key":"R46-11-20210202","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/BF00930955","article-title":"Tissue cyst rupture in mice chronically infected with toxoplasma gondii. An immunochemical and ultrastructural study.","volume":"75","author":"Ferguson","year":"1989","journal-title":"Parasitol Res"},{"key":"R47-11-20210202","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1462-5822.2005.00629.x","article-title":"Differential inductions of TNF-alpha and IGTP, IIGP by structurally diverse classic and non-classic lipopolysaccharides.","volume":"8","author":"Lapaque","year":"2006","journal-title":"Cell Microbiol"},{"key":"R48-11-20210202","first-page":"587","article-title":"Recognition of tissue cyst-specific antigens in reactivating toxoplasmosis. J Med.","volume":"46","author":"McHugh","year":"1997","journal-title":"Microbiol"},{"key":"R49-11-20210202","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1212\/WNL.43.10.2035","article-title":"Choroid plexus infection in cerebral toxoplasmosis in AIDS patients.","volume":"43","author":"Falangola","year":"1993","journal-title":"Neurology"},{"key":"R50-11-20210202","first-page":"106","article-title":"Primary cerebral toxoplasmosis: a rare case of ventriculitis and hydrocephalus in AIDS.","volume":"24","author":"Sell","year":"2005","journal-title":"Clin Neuropathol"},{"key":"R51-11-20210202","first-page":"55","article-title":"Hydrocephalus and prominence of the choroid plexus: an unusual computed tomographic presentation of cerebral toxoplasmosis in AIDS.","volume":"43","author":"Bourgouin","year":"1992","journal-title":"Can Assoc Radiol J"},{"key":"R52-11-20210202","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1017\/S0031182096008505","article-title":"Pathogenesis of murine toxoplasmic hydrocephalus.","volume":"114","author":"Stahl","year":"1997","journal-title":"Parasitology"},{"key":"R53-11-20210202","first-page":"969","article-title":"Decrease in interleukin 2-induced vascular leakage in the lungs of mice by administration of recombinant interleukin 1 alpha in vivo.","volume":"49","author":"Puri","year":"1989","journal-title":"Cancer Res"},{"key":"R54-11-20210202","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF00205236","article-title":"Combined effects of interferon alpha and interleukin 2 on the induction of a vascular leak syndrome in mice.","volume":"28","author":"Puri","year":"1989","journal-title":"Cancer Immunol Immunother"},{"key":"R55-11-20210202","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1177\/019262339402200404","article-title":"Interleukin-1 alpha reduces the severity of the vascular leak syndrome produced by interleukin-2 and interleukin-2 plus interferon-alpha.","volume":"22","author":"Fujita","year":"1994","journal-title":"Toxicol Pathol"},{"key":"R56-11-20210202","first-page":"1021","article-title":"Expression pattern and cellular origin of cytokines in the normal and toxoplasma gondii-infected murine brain.","volume":"150","author":"Schluter","year":"1997","journal-title":"Am J Pathol"},{"key":"R57-11-20210202","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.4049\/jimmunol.150.8.3404","article-title":"Effects of cytokines on multiplication of Toxoplasma gondii in microglial cells.","volume":"150","author":"Chao","year":"1993","journal-title":"J Immunol"},{"key":"R58-11-20210202","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1645\/GE-404R","article-title":"Suppressed cytokine and immunoglobulin secretions by murine splenic lymphocytes infected in vitro with toxoplasma gondii tachyzoites.","volume":"91-","author":"Guk","year":"2005","journal-title":"J Parasitol"},{"key":"R59-11-20210202","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0020-7519(03)00092-4","article-title":"Reduced expression of the inducible nitric oxide sythase after infection with toxoplasma gondii facilitates parasite replication in actived murine macrophages.","volume":"33","author":"Luder","year":"2003","journal-title":"Int J Parasitol"},{"key":"R60-11-20210202","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0167-5699(00)01616-9","article-title":"Tryptophan degradation to control T-cell responsiveness.","volume":"21","author":"Widner","year":"2000","journal-title":"Immunol Today"},{"key":"R61-11-20210202","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1084\/jem.20020121","article-title":"Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase.","volume":"196","author":"Frumento","year":"2002","journal-title":"J Exp Med"},{"key":"R62-11-20210202","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1084\/jem.20020052","article-title":"Inhibition of allegeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites.","volume":"196","author":"Terness","year":"2002","journal-title":"J Exp Med"},{"key":"R63-11-20210202","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/brain\/115.5.1249","article-title":"Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.","volume":"115","author":"Heyes","year":"1992","journal-title":"Brain"},{"key":"R64-11-20210202","first-page":"881","article-title":"Sources of the neurotoxin quinolinic acid in the brain of HIV-1-infected patients and retrovirus-infected macaques.","volume":"12","author":"Heyes","year":"1998","journal-title":"FASEB J"},{"key":"R65-11-20210202","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.4049\/jimmunol.150.9.4031","article-title":"Picolinic acid, a catabolite of L-tryptophan, is a costimulus for the induction of reactive nitrogen intermediate production in murine macropahages.","volume":"150","author":"Melillo","year":"1993","journal-title":"J Immunol"},{"key":"R66-11-20210202","doi-asserted-by":"crossref","first-page":"14457","DOI":"10.1016\/S0021-9258(17)36645-0","article-title":"Nitric oxide inhibits indoleamine 2,3-dioxygenase activity in interferon- primed mononuclear phagocytes.","volume":"269","author":"Thomas","year":"1994","journal-title":"J Biol Chem"},{"key":"R67-11-20210202","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00002826-200305000-00005","article-title":"Medications and substances as a cause of headache: a systematic review of the literature.","volume":"26","author":"Toth","year":"2003","journal-title":"Clin Neuropharmacol"},{"key":"R68-11-20210202","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1042\/bj2830633","article-title":"Human macrophages convert L-tryptophan into the neurotoxin quinolinic acid.","volume":"283","author":"Heyes","year":"1992","journal-title":"Biochem J"},{"key":"R69-11-20210202","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1096\/fasebj.5.11.1907934","article-title":"Relationship between interferon-, indoleamine 2,3-dioxygenase, and tryptophan catabolism.","volume":"5","author":"Taylor","year":"1991","journal-title":"FASEB J"},{"key":"R70-11-20210202","first-page":"251","article-title":"Modulation of CYP1A2 enzyme activity by indoleamines: inhibition by serotonin and tryptamine.","volume":"8","author":"Agundez","year":"1998","journal-title":"Pharmacogenetics"},{"key":"R71-11-20210202","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0171-2985(99)80066-7","article-title":"Genes, cells and cytokines in resistance against development of toxoplasmic encephalitis.","volume":"201","author":"Suzuki","year":"1999","journal-title":"Immunobiology"},{"key":"R72-11-20210202","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1128\/IAI.71.7.4171-4174.2003","article-title":"Different strains of Toxoplasma gondii induce different cytokine responses in CBA\/Ca mice.","volume":"71","author":"Araujo","year":"2003","journal-title":"Infect Immun"},{"key":"R73-11-20210202","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1128\/MR.59.4.533-547.1995","article-title":"Role of nitric oxide in parasitic infections.","volume":"59","author":"James","year":"1995","journal-title":"Microbiol Rev"},{"key":"R74-11-20210202","doi-asserted-by":"crossref","first-page":"5453","DOI":"10.4049\/jimmunol.153.12.5453","article-title":"Outcome of Kupffer cell antigen presentation to a cloned murine Th1 lymphocyte depends on the inducibility of nitric oxide synthase by IFN-.","volume":"153","author":"Roland","year":"1994","journal-title":"J Immunol"},{"key":"R75-11-20210202","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.4049\/jimmunol.153.3.1293","article-title":"Inhibition of macrophage Ia expression by nitric oxide.","volume":"153","author":"Sicher","year":"1994","journal-title":"J Immunol"},{"key":"R76-11-20210202","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nrd870","article-title":"Endogenous kynurenines as targets for drug discovery and development.","volume":"15","author":"Stone","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"R77-11-20210202","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-2249.2004.02515.x","article-title":"Iron down-regulates macrophage anti-tumour activity by blocking nitric oxide production.","volume":"137","author":"Harhaji","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"R78-11-20210202","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-3024.1994.tb00353.x","article-title":"Temporal differences in the expression of mRNA for IL-10 and IFN-gamma in the brains and spleens of C57BL\/10 mice infected with Toxoplasma gondii.","volume":"16","author":"Burke","year":"1994","journal-title":"Parasite Immunol"},{"key":"R79-11-20210202","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1046\/j.1526-4610.2001.041007629.x","article-title":"Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness?","volume":"41","author":"Welch","year":"2001","journal-title":"Headache"},{"key":"R80-11-20210202","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0090-6980(96)00056-1","article-title":"PGE2 and LTB4 inhibit cytokine-stimulated nitric oxide synthase type 2 expression in isolated rat hepatocytes.","volume":"52","author":"Harbrecht","year":"1996","journal-title":"Prostaglandins"},{"key":"R81-11-20210202","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/jlb.61.6.712","article-title":"Timing of prostaglandin exposure is critical for the inhibition of LPS- or IFN-gamma-induced macrophage NO synthesis by PGE2.","volume":"61","author":"Harbrecht","year":"1997","journal-title":"J Leukoc Biol"},{"key":"R82-11-20210202","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/hep.510280519","article-title":"Macrophage-induced inhibition of nitric oxide production in primary rat hepatocyte cultures via prostaglandin E2 release.","volume":"28","author":"Griffon","year":"1998","journal-title":"Hepatology"},{"key":"R83-11-20210202","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1006\/bbrc.1993.1836","article-title":"Nitric oxide mediates interleukin-1-induced prostaglandin E2 production by vascular smooth muscle cells.","volume":"194","author":"Inoue","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"R84-11-20210202","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1128\/IAI.62.5.1761-1767.1994","article-title":"Reduced replication of Toxoplasma gondii is necessary for induction of bradyzoite-specific antigens: a possible role for nitric oxide in triggering stage conversion.","volume":"62","author":"Bohne","year":"1994","journal-title":"Infect Immunol"},{"key":"R85-11-20210202","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0167-5699(91)90064-Z","article-title":"A new view of prostaglandin E regulation of the immune response.","volume":"12","author":"Phipps","year":"1991","journal-title":"Immunol Today"},{"key":"R86-11-20210202","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1046\/j.1365-2222.2003.01637.x","article-title":"In vitro effects of eicosanoids derived from different 20-carbon fatty acids on T helper type 1 and T helper type 2 cytokine production in human whole-blood cultures.","volume":"33","author":"Miles","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"R87-11-20210202","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1128\/IAI.71.4.2047-2057.2003","article-title":"Soluble factors release by Toxoplasma gondii-infected astrocytes down-modulate nitric oxide production by gamma interferon-activated microglia and prevent neuronal degeneration.","volume":"71","author":"Rozenfeld","year":"2003","journal-title":"Infect Immun"},{"key":"R88-11-20210202","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/(SICI)1097-4547(19990615)56:6<571::AID-JNR3>3.0.CO;2-P","article-title":"Opposite effects of interferon-gamma and prostaglandin E2 on tumor necrosis factor and interleukin-10 production in microglia: a regulatory loop controlling microglia pro- and anti-inflammatory activities.","volume":"56","author":"Aloisi","year":"1999","journal-title":"J Neurosci Res"},{"key":"R89-11-20210202","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1073\/pnas.81.3.908","article-title":"Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cell to degrade tryptophan.","volume":"81","author":"Pfefferkorn","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"key":"R90-11-20210202","doi-asserted-by":"crossref","first-page":"6329","DOI":"10.4049\/jimmunol.151.11.6329","article-title":"Inducible nitric oxide synthase from a rat alveolar macrophage cell line is inhibited by nitric oxide.","volume":"151","author":"Griscavage","year":"1993","journal-title":"J Immunol"},{"key":"R91-11-20210202","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1006\/abbi.1997.9913","article-title":"Inhibition of nitric oxide synthase expression and activity in macrophages by 3-hydroxyanthranilic acid, a tryptophan metabolite.","volume":"340","author":"Sekkai","year":"1997","journal-title":"Arch Biochem Biophys"},{"key":"R92-11-20210202","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1080\/10715760400011437","article-title":"Tryptophan loading induces oxydative stress.","volume":"38","author":"Forrest","year":"2004","journal-title":"Free Radic Res"},{"key":"R93-11-20210202","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMra020100","article-title":"The effect of infections on susceptibility to autoimmune and allergic diseases.","volume":"347","author":"Bach","year":"2002","journal-title":"N Engl J Med"},{"key":"R94-11-20210202","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0091-6749(05)80010-7","article-title":"Decreased interferon gamma and increased interleukin-4 production in atopic dermatitis promotes IgE synthesis.","volume":"90","author":"Jujo","year":"1992","journal-title":"J Allergy Clin Immunol"},{"key":"R95-11-20210202","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/B:VIRU.0000012260.32578.72","article-title":"The changes in the T helper 1 (Th1) and T helper 2 (Th2) cytokine balance during HIV-1 infection are indicative of an allergic response to viral proteins that may be reversed by Th2 cytokine inhibitors and immune response modifiers-a review and hypothesis.","volume":"28","author":"Becker","year":"2004","journal-title":"Virus Genes"},{"key":"R96-11-20210202","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0167-5699(93)90208-3","article-title":"A Th1 TH2 switch is a critical step in the etiology of HIV infection.","volume":"14","author":"Clerici","year":"1993","journal-title":"Immunol Today"},{"key":"R97-11-20210202","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0923-1811(01)00174-8","article-title":"Flow cytometric analysis of IL-4, IL-13 and IFN-gamma expression in peripheral blood mononuclear cells and detection of circulating IL-13 in patients with atopic dermatitis provide evidence for the involvement of type 2 cytokines in the disease.","volume":"29","author":"Kaminishi","year":"2002","journal-title":"J Dermatol Sci"},{"key":"R98-11-20210202","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.molimm.2005.06.022","article-title":"Indoleamine 2,3-dioxygenase activity is lower in atopic than non-atopic individuals and is enhanced by environmental factors protecting from atopy.","volume":"43","author":"Raitala","year":"2006","journal-title":"Mol Immunol"},{"key":"R99-11-20210202","doi-asserted-by":"crossref","first-page":"S234","DOI":"10.1086\/344276","article-title":"Immunopathogenesis of cerebral toxoplasmosis.","volume":"186","author":"Suzuki","year":"2002","journal-title":"J Infect Dis"},{"key":"R100-11-20210202","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1046\/j.1365-2222.2002.01391.x","article-title":"Increased Th1 and Th2 allergen-induced cytokine responses in children with atopic disease.","volume":"32","author":"Smart","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"R101-11-20210202","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1128\/CMR.10.4.742","article-title":"A primer on cytokines: sources, receptors, effects and inducers.","volume":"10","author":"Curfs","year":"1997","journal-title":"Clin Microbiol Rev"},{"key":"R102-11-20210202","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1006\/cyto.1996.0087","article-title":"Biomolecular regulation of the IgE immune response III. Cytokine profiles in atopic dermatitis, inhallant allergy and non-allergic donors.","volume":"8","author":"Poulsen","year":"1996","journal-title":"Cytokine"},{"key":"R103-11-20210202","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/icb.1995.9","article-title":"Interleukin-4 inhibits the expression of tumor necrosis factors and , interleukin-1 and -6 and interferon-.","volume":"73","author":"Lee","year":"1995","journal-title":"Immunol Cell Biol"},{"key":"R104-11-20210202","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0014-5793(93)80806-6","article-title":"Interleukin 4 inhibits the production of some acute-phase proteins by human hepatocytes in primary culture.","volume":"336","author":"Loyer","year":"1993","journal-title":"FEBS Lett"},{"key":"R105-11-20210202","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1128\/IAI.68.6.3426-3430.2000","article-title":"Investigation into the mechanism of gamma interferon-mediated inhibition of Toxoplasma gondii in murine astrocytes.","volume":"68","author":"Halonen","year":"2000","journal-title":"Infect Immun"},{"key":"R106-11-20210202","doi-asserted-by":"crossref","first-page":"9811","DOI":"10.1016\/S0021-9258(17)36955-7","article-title":"Interleukin-4 stimulates cGMP production by INF--activated human monocytes. Involvement of the nitric oxide synthase pathway.","volume":"269","author":"Kolb","year":"1994","journal-title":"J Biol Chem"},{"key":"R107-11-20210202","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1046\/j.1523-1747.2000.00847.x","article-title":"The modulation of cytokine and IgE production by tumor necrosis factor-beta in atopic dermatitis.","volume":"114","author":"Jirapongsananuruk","year":"2000","journal-title":"J Invest Dermatol"},{"key":"R108-11-20210202","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1046\/j.1365-2133.2002.05013.x","article-title":"Increased frequency of intracellular interleukin (IL)-13 and IL-10, but not IL-4, expressing CD4+ and CD8+ peripheral T cells of patients with atopic dermatitis.","volume":"147","author":"Aleksza","year":"2002","journal-title":"Br J Dermatol"},{"key":"R109-11-20210202","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S1081-1206(10)62471-4","article-title":"Effects of substance P and vasoactive intestinal peptide on interferon-gamma and interleukin-4 production in severe atopic dermatitis.","volume":"85","author":"Kang","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R110-11-20210202","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.4049\/jimmunol.142.11.3857","article-title":"IL-4 downregulates IL-1 and TNF gene expression in human monocytes.","volume":"142","author":"Essner","year":"1989","journal-title":"J Immunol"},{"key":"R111-11-20210202","first-page":"514","article-title":"Tumor necrosis factor production by IL-2-activated macrophages in vitro and in vivo.","volume":"67","author":"Economou","year":"1989","journal-title":"Immunology"},{"key":"R112-11-20210202","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/0169-4758(88)90003-8","article-title":"Oxidative killing of intracellular parasites mediated by macrophages.","volume":"4","author":"Hughes","year":"1988","journal-title":"Parasitol Today"},{"key":"R113-11-20210202","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.4049\/jimmunol.147.7.2340","article-title":"Tumor necrosis factor- triggers antitoxoplasmal activity of IFN- primed macrophages.","volume":"147","author":"Sibley","year":"1991","journal-title":"J Immunol"},{"key":"R114-11-20210202","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3109\/08820139309084178","article-title":"Nitric oxide mediates the toxoplasmastatic activity of murine microglial cells in vitro.","volume":"22","author":"Jun","year":"1993","journal-title":"Immunol Invest"},{"key":"R115-11-20210202","doi-asserted-by":"crossref","first-page":"568","DOI":"10.4049\/jimmunol.148.2.568","article-title":"IFN- induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-.","volume":"148","author":"Langermans","year":"1992","journal-title":"J Immunol"},{"key":"R116-11-20210202","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/infdis\/171.2.516","article-title":"Human astrocytes inhibit intracellular multiplication of Toxoplasma gondii by a nitric oxide-mediated mechanism.","volume":"171","author":"Peterson","year":"1995","journal-title":"J Infect Dis"},{"key":"R117-11-20210202","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0169-4758(91)90142-B","article-title":"Proposed link between cytokines, nitric oxide and human cerebral malaria.","volume":"7","author":"Clark","year":"1991","journal-title":"Parasitol Today"},{"key":"R118-11-20210202","first-page":"1021","article-title":"Role of interleukin-4 in the regulation of nitric oxide production by normal human monocytes.","volume":"317","author":"Defer","year":"1994","journal-title":"C R Acad Sci III"},{"key":"R119-11-20210202","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/jlb.56.1.15","article-title":"Heterogenous spontaneous and interleukin-4-induced nitric oxide production by human monocytes.","volume":"56","author":"Mautino","year":"1994","journal-title":"J Leukoc Biol"},{"key":"R120-11-20210202","doi-asserted-by":"crossref","first-page":"13955","DOI":"10.1073\/pnas.94.25.13955","article-title":"A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice.","volume":"94","author":"Khan","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"R121-11-20210202","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/archneur.1975.00490470079012","article-title":"Acquired toxoplasmosis. A neglected cause of treatable nervous system disease.","volume":"32","author":"Townsend","year":"1975","journal-title":"Arch Neurol"},{"key":"R122-11-20210202","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1128\/IAI.64.3.897-904.1996","article-title":"Different roles for interleukin-4 during the course of Toxoplasma gondii infection.","volume":"64","author":"Roberts","year":"1996","journal-title":"Infect Immun"},{"key":"R123-11-20210202","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.4049\/jimmunol.148.6.1725","article-title":"IL-4 suppresses cytokine gene expression induced by IFN- and\/or IL-2 in murine peritoneal macrophages.","volume":"148","author":"Gautum","year":"1992","journal-title":"J Immunol"},{"key":"R124-11-20210202","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0952-7915(93)90031-M","article-title":"Type 2 cytokines and negative immune regulation in human infections.","volume":"3","author":"Modulin","year":"1993","journal-title":"Curr Opin Immunol"},{"key":"R125-11-20210202","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/infdis\/174.5.1080","article-title":"Interleukin(IL)-6 and IL-8 in children with febrile urinary tract infection and asymptomatic bacteriuria.","volume":"174","author":"Benson","year":"1996","journal-title":"J Infect Dis"},{"key":"R126-11-20210202","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000187923","article-title":"Interleukin-6 and interleukin-8 in serum and urine in patients with acute pyelonephritis in relation to bacterial-virulence-associated traits and renal function.","volume":"67","author":"Jacobson","year":"1994","journal-title":"Nephron"},{"key":"R127-11-20210202","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s004670000456","article-title":"Urinary interleukin-6 and interleukin-8 in children with urinary tract infection.","volume":"15","author":"Jantausch","year":"2000","journal-title":"Pediatr Nephrol"},{"key":"R128-11-20210202","first-page":"255","article-title":"The cascade of inflammatory cytokines regulating synthesis of acute phase proteins.","volume":"13","author":"Koj","year":"1988","journal-title":"Tokai J Exp Clin Med"},{"key":"R129-11-20210202","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1096\/fj.03-0969fje","article-title":"Novel immunosuppressive properties of interleukin-6 in dendritic cells: inhibition of NF-kappaB binding activity and CCR7 expression.","volume":"18","author":"Hedge","year":"2004","journal-title":"FASEB J"},{"key":"R130-11-20210202","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/jlb.67.3.312","article-title":"Activation of macrophages by food antigens: enhancing effect of gluten on nitric oxide and cytokine production.","volume":"67","author":"Tuckova","year":"2000","journal-title":"J Leukoc Biol"},{"key":"R131-11-20210202","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1572-0241.2003.07300.x","article-title":"Association between migraine and celiac disease: results from a preliminary case-control and therapeutic study.","volume":"98","author":"Gabrielli","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"R132-11-20210202","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1468-2982.1987.0702125.x","article-title":"Bilateral cerebral occipital calcifications and migraine-like headache.","volume":"7","author":"Battistella","year":"1987","journal-title":"Cephalagia"},{"key":"R133-11-20210202","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1365-3083.1999.00523.x","article-title":"Cytokine profile in celiac disease.","volume":"49","author":"Lahat","year":"1999","journal-title":"Scand J Immunol"},{"key":"R134-11-20210202","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0887-8994(02)00466-6","article-title":"The diet factor in pediatric and adolescent migraine.","volume":"28","author":"Millichap","year":"2003","journal-title":"Pediatr Neurol"},{"key":"R135-11-20210202","first-page":"676","article-title":"Lancet.","volume":"1","year":"1973","journal-title":""},{"key":"R136-11-20210202","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0091-6749(86)90010-2","article-title":"A critical evaluation of clinical trial in adverse reactions to food in adults.","volume":"78","author":"Atkins","year":"1986","journal-title":"J Allergy Clin Immunol"},{"key":"R137-11-20210202","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1046\/j.1526-4610.2002.02143.x","article-title":"Chronic daily headache: identification of factors associated with induction and transformation.","volume":"42","author":"Bigal","year":"2002","journal-title":"Headache"},{"key":"R138-11-20210202","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1046\/j.1468-2982.1999.019002088.x","article-title":"Cluster headache and lifestyle: remarks on a population of 374 male patients.","volume":"19","author":"Manzoni","year":"1999","journal-title":"Cephalalgia"},{"key":"R139-11-20210202","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1042\/bj3080231","article-title":"Ethanol potentiates interleukin-1 beta-stimulated inducible nitric oxide synthase expression in cultured vascular smooth muscle cells.","volume":"308","author":"Durante","year":"1995","journal-title":"Biochem J"},{"key":"R140-11-20210202","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00000542-198102000-00005","article-title":"Neurological changes during awakening from anesthesia.","volume":"54","author":"Rosenberg","year":"1981","journal-title":"Anesthesiology"},{"key":"R142-11-20210202","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/bja\/77.2.238","article-title":"Ketamine inhibits nitric oxide production in mouse-activated macrophage-like cells.","volume":"77","author":"Shimaoka","year":"1996","journal-title":"Br J Anaesth"},{"key":"R143-11-20210202","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1046\/j.1526-4610.2001.041007733.x","article-title":"NMDA receptor blockade prevents nitroglycerin-induced headache.","volume":"41","author":"Roffey","year":"2001","journal-title":"Headache"},{"key":"R144-11-20210202","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1592\/phco.19.1.94.30512","article-title":"Comparison of 24-hour ambulatory blood pressure data in hypertensive patients switched from nifedipine-GITS to nifedipine-CC.","volume":"19","author":"Wurdeman","year":"1999","journal-title":"Pharmacotherapy"},{"key":"R145-11-20210202","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1046\/j.1526-4610.2001.111006084.x","article-title":"Migraine with aura after administration of sublingual nitroglycerin tablets.","volume":"41","author":"Bank","year":"2001","journal-title":"Headache"},{"key":"R146-11-20210202","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/35096564","article-title":"Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors.","volume":"413","author":"Jutel","year":"2001","journal-title":"Nature"},{"key":"R147-11-20210202","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/archneur.1968.00480050057005","article-title":"Nitroglycerin as a provocative agent in cluster headache.","volume":"19","author":"Ekbom","year":"1968","journal-title":"Arch Neurol"},{"key":"R148-11-20210202","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1046\/j.1468-2982.1987.0701039.x","article-title":"Whole blood and plasma histamine in common migraine.","volume":"7","author":"Haimart","year":"1987","journal-title":"Cephalalgia"},{"key":"R149-11-20210202","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1046\/j.1468-2982.2000.00068.x","article-title":"Induction of nitrate tolerance is not a useful treatment in cluster headache.","volume":"20","author":"Christiansen","year":"2000","journal-title":"Cephalagia"},{"key":"R150-11-20210202","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/0024-3205(95)02163-D","article-title":"Effects of calcium channel antagonists on the induction of nitric oxide synthase in cultured cells by immunostimulants.","volume":"57","author":"Hattori","year":"1995","journal-title":"Life Sci"},{"key":"R152-11-20210202","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/00003495-198325020-00001","article-title":"Calcium antagonists. Pharmacodynamic effects of management of action.","volume":"25","author":"Zsoter","year":"1983","journal-title":"Drugs"},{"key":"R153-11-20210202","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1254\/jjp.89.157","article-title":"Amlodipine inhibits proinflammatory cytokines and free radical production and inducible nitric oxide synthase expression in lipopolysaccharide\/interferon-gamma-stimulated cultured vascular smooth muscle cells.","volume":"89","author":"Chou","year":"2002","journal-title":"Jpn J Pharmacol"},{"key":"R154-11-20210202","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/01.HYP.36.2.270","article-title":"Nifedipine increases cytochrome P4502C expression and endothelium-derived hyperpolarizing factor-mediated responses in coronary arteries.","volume":"36","author":"Fisslthalter","year":"2000","journal-title":"Hypertension"},{"key":"R155-11-20210202","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/BF00148477","article-title":"Calcium-channel blockade (nitrendipine) in combination with ACE inhibition (captopril) in the treatment of mild to moderate hypertension.","volume":"3","author":"Gennari","year":"1989","journal-title":"Cardiovasc Drugs Ther"},{"key":"R156-11-20210202","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/01.HYP.25.4.764","article-title":"Cyclosporin A inhibits nitric oxide synthase induction in vascular smooth muscle cells.","volume":"25","author":"Marumo","year":"1995","journal-title":"Hypertension"},{"key":"R157-11-20210202","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1526-4610.2005.05046.x","article-title":"Calcineurin inhibitor-induced headache: clinical characteristics and possible mechanisms.","volume":"45","author":"Ferrari","year":"2005","journal-title":"Headache"},{"key":"R158-11-20210202","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0014-2999(95)00712-1","article-title":"Dipyridamole enhances interleukin-1beta-stimulated nitric oxide production by cultured rat vascular smooth muscle cells.","volume":"296","author":"Iimura","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"R161-11-20210202","doi-asserted-by":"crossref","first-page":"770","DOI":"10.4065\/78.6.770","article-title":"Sustained-release niacin for prevention of migraine headache.","volume":"78","author":"Velling","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"R162-11-20210202","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0090-6980(89)90088-9","article-title":"Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid.","volume":"38","author":"Morrow","year":"1989","journal-title":"Prostaglandins"},{"key":"R163-11-20210202","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1475-2891-4-3","article-title":"The treatment of migraines and tension-type headaches with intravenous and oral niacin (nicotinic acid): systematic review of the literature.","volume":"4","author":"Prousky","year":"2005","journal-title":"Nutr J"},{"key":"R165-11-20210202","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0140-6736(83)90495-6","article-title":"Intracranial hypertension with etretinate.","volume":"2","author":"Bonnetblanc","year":"1983","journal-title":"Lancet"},{"key":"R166-11-20210202","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0002-9343(54)90281-8","article-title":"Vitamin A poisoning in adults.","volume":"16","author":"Gerber","year":"1954","journal-title":"Am J Med"},{"key":"R167-11-20210202","first-page":"1420","article-title":"Pseudotumor cerebri caused by all-trans retinoic acid: a case report.","volume":"83","author":"Tiamkao","year":"2000","journal-title":"J Med Assoc Thai"},{"key":"R168-11-20210202","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1111\/j.1476-5381.1994.tb17159.x","article-title":"Inhibition of nitric oxide synthesis in vascular smooth muscle by retinoids.","volume":"113","author":"Hirokawa","year":"1994","journal-title":"Br J Pharmacol"},{"key":"R169-11-20210202","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1006\/bbrc.2000.2535","article-title":"Retinoic acid inhibits nitric oxide synthase-2 expression through retinoic acid receptor-alpha.","volume":"270","author":"Sirsjo","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"R170-11-20210202","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1526-4610.1989.hed2907441.x","article-title":"Drug-related headache.","volume":"29","author":"Askmark","year":"1989","journal-title":"Headache"},{"key":"R171-11-20210202","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1126\/science.163.3869.826","article-title":"Monosodium L-glutamate: its pharmacology and role in the Chinese restaurant syndrome.","volume":"163","author":"Schaumburg","year":"1969","journal-title":"Science"},{"key":"R172-11-20210202","first-page":"1617","article-title":"A questionnaire study of the prevalence of Chinese restaurant syndrome.","volume":"36","author":"Reif-Lehrer","year":"1977","journal-title":"Fed Proc"},{"key":"R173-11-20210202","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1006\/clim.1999.4788","article-title":"Effect of glutamine on Th1 and Th2 cytokine responses of human peripheral blood mononuclear cells.","volume":"93","author":"Chang","year":"1999","journal-title":"Clin Immunol"},{"key":"R174-11-20210202","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0091-6749(98)70187-3","article-title":"Aerosol beclomethasone dipropionate spray compared with theophylline as primary treatment for chronic mild-to-moderate asthma. The American Academy of Allergy, Asthma, and Immunology Beclomethasone Dipropionate-Theophylline Study Group.","volume":"101","author":"Reed","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"R175-11-20210202","first-page":"191","article-title":"In vivo, ex vivo, and in vitro effects of L-NAME and L-arginine on the metabolism of theophylline in the rabbit.","volume":"25","author":"Barakat","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"R176-11-20210202","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1155\/1998\/639710","article-title":"Comparison of budesonide Turbohaler with budesonide aqua in the treatment of seasonal allergic rhinitis. Rhinocort Study Group.","volume":"5","author":"Yang","year":"1998","journal-title":"Can Respir J"},{"key":"R177-11-20210202","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/0006-291X(87)91431-8","article-title":"The actions of interferon and antiinflammatory agents on induction of indoleamine 2,3-dioxygenase in human peripheral blood monocytes.","volume":"144","author":"Ozaki","year":"1987","journal-title":"Biochem Biophys Res Commun"},{"key":"R178-11-20210202","doi-asserted-by":"crossref","first-page":"7327","DOI":"10.1073\/pnas.78.12.7327","article-title":"Inhibition of interferon-mediated induction of indoleamine 2,3-dioxygenase in mouse lung by inhibitors of prostaglandin biosynthesis.","volume":"78","author":"Sayama","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"key":"R179-11-20210202","doi-asserted-by":"crossref","first-page":"10043","DOI":"10.1073\/pnas.87.24.10043","article-title":"Glucocorticoids inhibit the expression of an inducible, but not the consitutive, nitric oxide synthase in vascular endothelial cells.","volume":"87","author":"Radomski","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"R180-11-20210202","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1254\/jjp.63.361","article-title":"Dexamethasone inhibits nitric oxide synthase mRNA induction by interleukin-1 alpha and tumor necrosis factor-alpha in vascular smooth muscle cells.","volume":"63","author":"Marumo","year":"1993","journal-title":"Jpn J Pharmacol"},{"key":"R181-11-20210202","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3347\/kjp.2006.44.3.209","article-title":"Cytokine and antibody responses of reactivated murine toxoplasmosis upon administration of dexamthasone.","volume":"44","author":"Kang","year":"2006","journal-title":"Korean J Parsitol"},{"key":"R182-11-20210202","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1081-1206(10)62307-1","article-title":"Antileukotriene Working Group. Safety of antileukotriene agents in asthma management.","volume":"86","author":"Spector","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R183-11-20210202","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1750-3639.2000.tb00248.x","article-title":"Inflammatory mediators of cerebral endothelium: a role in ischemic brain inflammation.","volume":"10","author":"Stanimirowic","year":"2000","journal-title":"Brain Pathol"},{"key":"R185-11-20210202","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1084\/jem.180.5.1637","article-title":"Toxoplasma gondii alters eicosanoid release by human mononuclear phagocytes: role of leukotrienes in interferon -induced antitoxoplasma activity.","volume":"180","author":"Yong","year":"1994","journal-title":"J Exp Med"},{"key":"R186-11-20210202","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1291\/hypres.26.177","article-title":"Lipoxygenase products regulate nitric oxide and inducible nitric oxide synthase production in interleukin-1beta stimulated vascular smooth muscle cells.","volume":"26","author":"Hashimoto","year":"2003","journal-title":"Hypertens Res"},{"key":"R187-11-20210202","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1212\/WNL.40.1.163","article-title":"Drug-induced meningitis.","volume":"40","author":"Gordon","year":"1990","journal-title":"Neurology"},{"key":"R188-11-20210202","first-page":"1841","article-title":"Aseptic meningitis as an adverse effect of co-trimoxazole.","volume":"308","author":"Kremer","year":"1983","journal-title":"N Engl J Med"},{"key":"R189-11-20210202","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1161\/01.CIR.99.14.1878","article-title":"Proinflammatory mediators downregulate the formation of the endothelium-derived hyperpolarizing factor in arteries via a nitric oxide\/cyclic GMP-dependent mechanism.","volume":"99","author":"Kessler","year":"1999","journal-title":"Circulation"},{"key":"R190-11-20210202","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/01.RES.88.1.44","article-title":"Endothelium-derived hyperpolarizing factor synthase (cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries.","volume":"88","author":"Fleming","year":"2001","journal-title":"Circ Res"},{"key":"R191-11-20210202","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1126\/science.285.5431.1276","article-title":"Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids.","volume":"285","author":"Node","year":"1999","journal-title":"Science"},{"key":"R192-11-20210202","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1124\/dmd.30.6.631","article-title":"Trimethoprim and sulfamethoxazole are selective inhibitors of CYP2C8 and 2C9, respectively.","volume":"30","author":"Wen","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"R193-11-20210202","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0165-0173(99)00014-4","article-title":"Neurodegenerative disorders: the role of peroxynitrite.","volume":"30","author":"Torreilles","year":"1999","journal-title":"Brain Res Brain Res Rev"},{"key":"R194-11-20210202","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1042\/bj2620861","article-title":"Parallel induction of tetrahydrobiopterin biosynthesis and indoleamine 2,3-dioxygenase activity in human cells and cell lines by interferon-.","volume":"262","author":"Werner","year":"1989","journal-title":"Biochem J"},{"key":"R195-11-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.102.034439","article-title":"Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities.","volume":"303","author":"Schwarcz","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"R196-11-20210202","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/clpt.1992.57","article-title":"Sulfamethoxazole is metabolized to the hydroxylamine in humans.","volume":"52","author":"Cribb","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"R197-11-20210202","first-page":"540","article-title":"The hydroxylamine of sulfamethoxazole synergizes with FK506 and cyclospirin A, inhibiting T-cell proliferation.","volume":"281","author":"Hess","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"R198-11-20210202","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1096\/fasebj.13.13.1688","article-title":"Cytotoxicity of CD8() cells by the hydroxylamine of sulfamethoxazole.","volume":"13","author":"Hess","year":"1999","journal-title":"FASB J"},{"key":"R199-11-20210202","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1096\/fj.00-0583fje","article-title":"inhibition of cytokine production and interference in IL-2 receptor mediated Jak-Stat signaling by the hydroxylamine metabolite of sulfamethoxazole.","volume":"15","author":"Hess","year":"2001","journal-title":"FASEB J"},{"key":"R201-11-20210202","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1136\/jnnp.54.9.803","article-title":"Cocaine-related vascular headaches.","volume":"54","author":"Dhuna","year":"1991","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R202-11-20210202","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1067\/msy.2001.115900","article-title":"Catecholamines decrease nitric oxide production by cytokine-stimulated hepatocytes.","volume":"130","author":"Collins","year":"2001","journal-title":"Surgery"},{"key":"R203-11-20210202","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1046\/j.1365-2567.2001.01332.x","article-title":"Adrenaline suppression of the macrophage nitric oxide response to lipopolysaccharide is associated with differential regulation of tumor necrosis factor-alpha and interleukin-10.","volume":"104","author":"Zinyama","year":"2001","journal-title":"Immunology"},{"key":"R204-11-20210202","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1526-4610.1968.hed0803084.x","article-title":"The role of tyramine in the etiology of migraine, and related studies on the cerebral and extracerebral circulations.","volume":"8","author":"Hanington","year":"1968","journal-title":"Headache"},{"key":"R206-11-20210202","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2165\/00003495-199856030-00012","article-title":"Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal inflammatory drugs.","volume":"56","author":"Langtry","year":"1998","journal-title":"Drugs"},{"key":"R207-11-20210202","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0039-6060(05)80339-3","article-title":"Cytochrome P450IIIA activity and cytokine-mediated synthesis of nitric oxide.","volume":"118","author":"Kuo","year":"1995","journal-title":"Surgery"},{"key":"R208-11-20210202","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1046\/j.1468-2982.1997.1708855.x","article-title":"A double-blind provocative study of chocolate as a trigger of headache.","volume":"17","author":"Marcus","year":"1997","journal-title":"Cephalalgia"},{"key":"R209-11-20210202","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0014-2999(97)01314-9","article-title":"Serotonin inhibits nitric oxide synthesis in rat vascular smooth muscle cells with interleukin-1.","volume":"338","author":"Shimpo","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"R210-11-20210202","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1182\/blood.V83.7.1831.1831","article-title":"Platelets inhibit the induction of nitric oxide synthesis by interleukin-1 beta in vascular smooth muscle cells.","volume":"83","author":"Durante","year":"1994","journal-title":"Blood"},{"key":"R211-11-20210202","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00008571-200102000-00004","article-title":"Inhibition of cytochrome P450 2C9 activity in vitro by 5-hydroxytryptamine and adrenaline.","volume":"11","author":"Gervasini","year":"2001","journal-title":"Pharmacogenetics"},{"key":"R212-11-20210202","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1161\/01.RES.71.5.1088","article-title":"Platelet-derived growth factor suppresses and fibroblast growth factor enhances cytokine-induced production of nitric oxide by cultured smooth muscle cells. Effects on cell proliferation.","volume":"71","author":"Scott-Burden","year":"1992","journal-title":"Circ Res"},{"key":"R213-11-20210202","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/sj.bjp.0705632","article-title":"5-Hydroxytryptamine is biotransformed by CYP2C9, 2C19 and 2B6 to hydroxylamine, which is converted into nitric oxide.","volume":"141","author":"Fradette","year":"2004","journal-title":"Br J Pharmacol"},{"key":"R214-11-20210202","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0893-133X(99)00150-5","article-title":"Effects of serotonin and serotonergic interleukin-10.","volume":"23","author":"Kubera","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"R215-11-20210202","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1526-4610.1992.hed3201035.x","article-title":"Ice cream headache-site, duration, and relationship to migraine.","volume":"32","author":"Bird","year":"1992","journal-title":"Headache"},{"key":"R216-11-20210202","doi-asserted-by":"crossref","first-page":"742","DOI":"10.2337\/diab.46.5.742","article-title":"Insulin stimulates nitric oxide synthesis in human platelets and, through nitric oxide, increases platelet concentrations of both guanosine-3,5-cyclic monophosphate and adenosine-3,5-cyclic monophosphate.","volume":"46","author":"Trovati","year":"1997","journal-title":"Diabetes"},{"key":"R217-11-20210202","first-page":"67","article-title":"Insulin secretion in migraine: influence on the blood levels of tryptophan.","volume":"3","author":"Poloni","year":"1976","journal-title":"Monogr Neural Sci"},{"key":"R218-11-20210202","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1161\/01.HYP.30.4.928","article-title":"Insulin acutely inhibits cultured vascular smooth muscle cell contraction by a nitric oxide synthase-dependent pathway.","volume":"30","author":"Kahn","year":"1997","journal-title":"Hypertension"},{"key":"R219-11-20210202","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1468-2982.1991.1102093.x","article-title":"Chocolate is a migraine-provoking agent.","volume":"11","author":"Gibb","year":"1991","journal-title":"Cephalalgia"},{"key":"R220-11-20210202","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s001250051100","article-title":"Insulin inhibits inducible nitric oxide synthase in skeletal muscle cells.","volume":"41","author":"Bedard","year":"1998","journal-title":"Diabetologia"},{"key":"R221-11-20210202","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/01.RES.74.1.24","article-title":"Insulin-like growth factor I inhibits induction of nitric oxide synthase in vascular smooth muscle cells.","volume":"74","author":"Schini","year":"1994","journal-title":"Circ Res"},{"key":"R222-11-20210202","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2337\/diabetes.48.4.855","article-title":"Hyperglycemia-induced activation of nuclear transcription factor kB in vascular smooth muscle cells.","volume":"48","author":"Yerneni","year":"1999","journal-title":"Diabetes"},{"key":"R223-11-20210202","first-page":"325","article-title":"High glucose concentrations increase the tumor necrosis factor-alpha production capacity by human peripheral blood mononuclear cells.","volume":"35","author":"Hancu","year":"1998","journal-title":"Rom J Physiol"},{"key":"R224-11-20210202","doi-asserted-by":"crossref","first-page":"954","DOI":"10.2337\/diab.45.7.954","article-title":"Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro.","volume":"45","author":"Morohoshi","year":"1996","journal-title":"Diabetes"},{"key":"R225-11-20210202","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1055\/s-2007-979789","article-title":"Elevated glucose levels stimulate transforming growth factor-beta 1 (TGF-beta 1), suppress interleukin 2, IL-6 and IL-10 production and DNA synthesis in peripheral blood mononuclear cells.","volume":"28","author":"Reinhold","year":"1996","journal-title":"Horm Metab Res"},{"key":"R226-11-20210202","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1161\/01.CIR.94.12.3109","article-title":"Long-term smoking impairs platelet-derived nitric oxide release.","volume":"94","author":"Ichiki","year":"1996","journal-title":"Circulation"},{"key":"R227-11-20210202","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2249.2005.02746.x","article-title":"Aspirin down-regulates tryptophan degradation in stimulated human peripheral mononuclear cells in vitro.","volume":"140","author":"Schroecksnadel","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"R228-11-20210202","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/archinte.1982.00340140167031","article-title":"Sulindac-induced aseptic meningitis.","volume":"142","author":"Ballas","year":"1982","journal-title":"Arch Intern Med"},{"key":"R229-11-20210202","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/jama.1981.03310260045029","article-title":"Tolmentin-induced aseptic meningitis.","volume":"245","author":"Ruppert","year":"1981","journal-title":"JAMA"},{"key":"R230-11-20210202","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/archinte.1980.00330220091037","article-title":"Aseptic meningitis associated with ibuprofen.","volume":"140","author":"Giansiracusa","year":"1980","journal-title":"Arch Intern Med"},{"key":"R231-11-20210202","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1345\/aph.1D581","article-title":"Possible trimethoprim\/sulfamethoxazole-induced aseptic meningitis.","volume":"38","author":"Therrien","year":"2004","journal-title":"Ann Pharmacother"},{"key":"R232-11-20210202","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1212\/WNL.39.12.1578","article-title":"Ibuprofen-induced meningitis: detection of intrathecal IgG synthesis and immune complexes.","volume":"39","author":"Chez","year":"1989","journal-title":"Neurology"},{"key":"R233-11-20210202","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1177\/106002808802200507","article-title":"Aseptic meningitis associated with naproxen.","volume":"22","author":"Sylvia","year":"1988","journal-title":"Drug Intell Clin Pharmacol"},{"key":"R234-11-20210202","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/hep.1840200430","article-title":"Modulation of hepatic mRNA levels after administration of lipopolysaccharide and diphtheria and tetanus toxoids and pertussis vaccine adsorbed (DTP vaccine) to mice.","volume":"20","author":"Ansher","year":"1994","journal-title":"Hepatology"},{"key":"R235-11-20210202","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/01.mjt.0000117501.97441.c92004","article-title":"Urinary tract diseases revealed after DTP vaccination in infants and young children. Cytokine irregularities and down-regulation of cytochrome P-450 enzymes induced by the vaccine may uncover latent diseases in genetically predisposed subjects.","volume":"11","author":"Prandota","year":"2004","journal-title":"Am J Ther"},{"key":"R236-11-20210202","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1128\/IAI.62.1.29-32.1994","article-title":"Depression of liver metabolism and induction of cytokine release by diphtheria and tetanus toxoids and pertussis vaccines: role of Bordetella pertussis cells in toxicity.","volume":"62","author":"Fantuzzi","year":"1994","journal-title":"Infect Immun"},{"key":"R237-11-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2567.1998.00401.x","article-title":"Distinct T-cell subtypes induced with whole and acellular pertussis vaccine in children.","volume":"93","author":"Ryan","year":"1998","journal-title":"Immunology"},{"key":"R238-11-20210202","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1128\/IAI.65.6.2168-2174.1997","article-title":"Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-c or acellular pertussis vaccines.","volume":"65","author":"Ausiello","year":"1997","journal-title":"Infect Immun"},{"key":"R239-11-20210202","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1023\/A:1023296022603","article-title":"Monokine production following in vitro stimulation of the THP-1 human monocytic cell line with pertussis vaccine components.","volume":"18","author":"Blood-Siegfried","year":"1998","journal-title":"J Clin Immunol"},{"key":"R241-11-20210202","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1056\/NEJM198608143150712","article-title":"Migraine provoked by aspartame.","volume":"315","author":"Johns","year":"1986","journal-title":"N Engl J Med"},{"key":"R242-11-20210202","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1056\/NEJM198711053171903","article-title":"Aspartame and susceptibility to headache.","volume":"317","author":"Schiffman","year":"1987","journal-title":"N Engl J Med"},{"key":"R243-11-20210202","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/ajcn\/68.3.531","article-title":"Aspartame: neuropsychologic and neurophysiologic evaluation of acute and chronic effects.","volume":"68","author":"Spiers","year":"1998","journal-title":"Am J Clin Nutr"},{"key":"R244-11-20210202","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1528-1157.1995.tb00995.x","article-title":"Aspartame and seizure susceptibility: results of a clinical study reportedly sensitive individuals.","volume":"36","author":"Rowan","year":"1995","journal-title":"Epilepsia"},{"key":"R245-11-20210202","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1515\/CCLM.2003.129","article-title":"Tryptophan metabolites and brain disorders.","volume":"41","author":"Stone","year":"2003","journal-title":"Clin Chem Lab Med"},{"key":"R246-11-20210202","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.bbrc.2004.06.061","article-title":"3-Hydroxyanthranilic acid, one of metabolites of tryptophan via indoleamine 2,3-dioxygenase pathway, suppresses inducible nitric oxide synthase expression by enhancing heme oxygenase-1 expression.","volume":"320","author":"Oh GSPae","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"R247-11-20210202","doi-asserted-by":"crossref","first-page":"419","DOI":"10.4049\/jimmunol.159.1.419","article-title":"Differential regulation of indoleamine 2,3-dioxygenase expression by nitric oxide and inflammatory mediators in IFN-gamma-activated murine macrophages and microglial cells.","volume":"159","author":"Alberati-Giani","year":"1997","journal-title":"J Immunol"},{"key":"R248-11-20210202","doi-asserted-by":"crossref","first-page":"6332","DOI":"10.4049\/jimmunol.166.10.6332","article-title":"Antioxidants inhibit indoleamine 2,3-dioxygenase in INF--activated human macrophages: posttranslational regulation by pyrrolidine dithiocarbamate.","volume":"166","author":"Thomas","year":"2001","journal-title":"J Immun"},{"key":"R249-11-20210202","first-page":"533","article-title":"Cytokine mediated regulation of interferon-gamma-induced IDO activation. Adv Exp Med.","volume":"467","author":"MacKenzie","year":"1999","journal-title":"Biol"},{"key":"R250-11-20210202","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1182\/blood.V83.5.1408.1408","article-title":"Interleukin-4 inhibits indoleamine 2,3-dioxygenase expression in human monocytes.","volume":"83","author":"Musso","year":"1994","journal-title":"Blood"},{"key":"R251-11-20210202","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/1521-4141(200102)31:2<333::AID-IMMU333>3.0.CO;2-X","article-title":"IL-4 and IL-13 regulate the induction of indoleamine 2,3-dioxygenase activity and the control of toxoplasma gondii in human fibroblasts activated with IFN-gamma.","volume":"31","author":"Chaves","year":"2001","journal-title":"Eur J Immunol"},{"key":"R252-11-20210202","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2005-03-0979","article-title":"A two step of indoleamine 2,3-dioxygenase (IDO) activity during dendritic cell maturation.","volume":"106","author":"Braun","year":"2005","journal-title":"Blood"},{"key":"R253-11-20210202","first-page":"931","article-title":"Interleukin-12 and interleukin-18 induce indoleamine 2,3-dioxygenase (IDO) activity in human osteosarcoma cell lines independently from interferon-gamma.","volume":"22","author":"Liebau","year":"2002","journal-title":"Anticancer Res"},{"key":"R254-11-20210202","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF01345271","article-title":"Expression of the kynurenine enzymes in macrophages and microglial cells: regulation by immune modulators.","volume":"14","author":"Alberati-Giani","year":"1998","journal-title":"Amino Acids"},{"key":"R255-11-20210202","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/(SICI)1097-4652(199810)177:1<174::AID-JCP18>3.0.CO;2-D","article-title":"Modulation of cellular tryptophan metabolism in human fibroblasts by transforming growth factor-beta: selective inhibition of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA synthetase gene expression.","volume":"177","author":"Yuan","year":"1998","journal-title":"J Cell Physiol"},{"key":"R256-11-20210202","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1126\/science.1281928","article-title":"Biochemistry of nitric oxide and its redox-activated forms.","volume":"258","author":"Stamler","year":"1992","journal-title":"Science"},{"key":"R257-11-20210202","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1161\/01.HYP.31.1.218","article-title":"Phospholipase A2 metabolites regulate inducible nitric oxide synthase in myocytes.","volume":"31","author":"LaPointe","year":"1998","journal-title":"Hypertension"},{"key":"R258-11-20210202","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1128\/IAI.70.5.2368-2374.2002","article-title":"Dendritic cells as effector cells: gamma interferon activation of murine dendritic cells triggers oxygen-dependent inhibition of Toxoplasma gondii replication.","volume":"70","author":"Aline","year":"2002","journal-title":"Infect Immun"},{"key":"R259-11-20210202","doi-asserted-by":"crossref","first-page":"20399","DOI":"10.1074\/jbc.271.34.20399","article-title":"Identification of a novel GTPase, the inducibly expressed GTPase, that accumulates in response to interferon .","volume":"271","author":"Taylor","year":"1996","journal-title":"J Biol Chem"},{"key":"R260-11-20210202","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1046\/j.1365-2567.1998.00553.x","article-title":"Interferon-gamma-activated primary enterocytes inhibit Toxoplasma gondii replication: a role for intracellular iron.","volume":"94","author":"Dimier","year":"1998","journal-title":"Immunology"},{"key":"R261-11-20210202","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/1367-8280(94)90083-3","article-title":"NO as an effector molecule of parasite killing: modulation of its synthesis by cytokines.","volume":"108","author":"Oswald","year":"1994","journal-title":"Comp Biochem Physiol Pharmacol Toxicol Endocrinol"},{"key":"R262-11-20210202","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0006-291X(88)80015-9","article-title":"Nitric oxide: a cytotoxic activated macrophage effector molecule.","volume":"157","author":"Hibbs","year":"1988","journal-title":"Biochem Biophys Res Commun"},{"key":"R263-11-20210202","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1006\/clin.1993.1062","article-title":"Activated microglia inhibit Toxoplasma gondii via a nitric oxide mechanism.","volume":"67","author":"Chao","year":"1993","journal-title":"Clin Immunol Immunopathol"},{"key":"R264-11-20210202","doi-asserted-by":"crossref","first-page":"11147","DOI":"10.1073\/pnas.90.23.11147","article-title":"Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants.","volume":"90","author":"Khatsenko","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"R265-11-20210202","first-page":"1479","article-title":"Irreversible inhibition of cytochrome P450 by nitric oxide.","volume":"283","author":"Minamiyama","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"R266-11-20210202","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1161\/01.CIR.0000034445.31543.43","article-title":"Red wine polypheols enhance endothelial nitric oxide sythase expression and subsequent nitric oxide release from endothelial cells.","volume":"106","author":"Leikert","year":"2002","journal-title":"Circulation"},{"key":"R267-11-20210202","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0006-291X(92)92400-R","article-title":"Interferon-gamma inhibits proliferation of rat vascular smooth muscle by nitric oxide generation.","volume":"188","author":"Nunokawa","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"key":"R268-11-20210202","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2165\/00023210-199402060-00002","article-title":"The role of nitric oxide in migraine pain. Therapeutic implications.","volume":"2","author":"Thomsen","year":"1994","journal-title":"CNS Drugs"},{"key":"R269-11-20210202","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1468-2982.1998.1801027.x","article-title":"Nitric oxide synthase inhibition: a new principle in the treatment of migraine attacks.","volume":"18","author":"Lassen","year":"1998","journal-title":"Cephalalgia"},{"key":"R270-11-20210202","doi-asserted-by":"crossref","first-page":"7738","DOI":"10.1073\/pnas.82.22.7738","article-title":"Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide.","volume":"82","author":"Stuehr","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"R271-11-20210202","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1677\/joe.0.1550567","article-title":"Transforming growth factor 1 prevents cytokine-mediated inhibitory effects and induction of nitric oxide synthase in the RINm5F insulin-containing -cell line.","volume":"155","author":"Mabley","year":"1997","journal-title":"J Endocrinol"},{"key":"R272-11-20210202","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0165-5728(93)90229-R","article-title":"Induction of nitric oxide synthase activity in human astrocytes by interleukin-1 beta and interferon gamma.","volume":"46","author":"Lee","year":"1993","journal-title":"J Neuroimmunol"},{"key":"R273-11-20210202","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1084\/jem.180.1.365","article-title":"Human astrocytes inhibit Cryptococcus neoformans growth by a nitric oxide-mediated mechanism.","volume":"180","author":"Lee","year":"1994","journal-title":"J Exp Med"},{"key":"R274-11-20210202","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/jnci\/84.13.1008","article-title":"Inhibition of interleukin-1-alpha-induced nitric oxide synthase in vascular smooth muscle and full reversal of interleukin-1-alpha-induced hypotension by N-omega-amino-L-arginine.","volume":"84","author":"Kilbourn","year":"1992","journal-title":"J Natl Cancer Inst"},{"key":"R275-11-20210202","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/jnci\/82.9.772","article-title":"Endothelial cell production of nitrogen oxides in response to interferon- in combination with tumor necrosis factor, interleukin-1, or endotoxin.","volume":"82","author":"Kilbourn","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"R276-11-20210202","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/0092-8674(92)90301-R","article-title":"Nitric oxide, a novel biologic messenger.","volume":"70","author":"Lovenstein","year":"1992","journal-title":"Cell"},{"key":"R277-11-20210202","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1084\/jem.172.6.1599","article-title":"Tetrahydrobiopterin dependent formation of nitrite and nitrate in murine fibroblasts.","volume":"172","author":"Werner-Felmayer","year":"1990","journal-title":"J Exp Med"},{"key":"R278-11-20210202","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1084\/jem.176.1.261","article-title":"Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin.","volume":"176","author":"Nussler","year":"1992","journal-title":"J Exp Med"},{"key":"R279-11-20210202","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1046\/j.1468-2982.2002.00310.x","article-title":"CGRP may play a causative role in migraine.","volume":"22","author":"Lassen","year":"2002","journal-title":"Cephalalgia"},{"key":"R280-11-20210202","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/brain\/awg009","article-title":"Migraine can be induced by sildenafil without changes in middle cerebral artery diameter.","volume":"126","author":"Kruuse","year":"2003","journal-title":"Brain"},{"key":"R281-11-20210202","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ana.410280213","article-title":"Vasoactive peptide release in the extracerebral circulation of humans during migraine headache.","volume":"28","author":"Goadsby","year":"1990","journal-title":"Ann Neurol"},{"key":"R282-11-20210202","first-page":"H2483","article-title":"CGRP enhances induction of NO synthase in vascular smooth muscle cells via a cAMP-dependent mechanism.","volume":"267","author":"Schini-Kerth","year":"1994","journal-title":"Am J Physiol"},{"key":"R283-11-20210202","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000158996","article-title":"Eicosapentaenoic acid potentiates the production of nitric oxide evoked by interleukin-1 beta in cultured vascular smooth muscle cells.","volume":"30","author":"Schini","year":"1993","journal-title":"J Vasc Res"},{"key":"R284-11-20210202","first-page":"H519","article-title":"Mechanism of action of cerebral epoxyeicosatrienoic acids on cerebral arterial smooth muscle.","volume":"263","author":"Gebremedhin","year":"1992","journal-title":"Am J Physiol"},{"key":"R285-11-20210202","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1098-8823(03)00077-7","article-title":"Role of cytochrome P450-dependent arachidonic acid acid metabolites in liver physiology and pathology.","volume":"72","author":"Sacerdoti","year":"2003","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"R286-11-20210202","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1468-2982.1998.1804197.x","article-title":"Flow cytometric analysis of lymphocyte subsets in migraine patients during and outside of an acute headache attack.","volume":"18","author":"Mosnaim","year":"1998","journal-title":"Cephalalgia"},{"key":"R287-11-20210202","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1468-2982.1999.019008713.x","article-title":"T-cell subsets and expression of integrins in peripheral blood of patients with migraine.","volume":"19","author":"Empl","year":"1999","journal-title":"Cephalalgia"},{"key":"R288-11-20210202","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1046\/j.1468-2982.1994.1402139.x","article-title":"Leukocyte subsets and cortisol serum levels in patients with migraine without aura and chronic tension-type headache.","volume":"14","author":"Leone","year":"1994","journal-title":"Cephalalgia"},{"key":"R289-11-20210202","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF02335750","article-title":"Monocyte chemotactic and phagocytic responses in migraine and tension-type headache patients.","volume":"14","author":"Gallai","year":"1993","journal-title":"Ital J Neurol Sci"},{"key":"R290-11-20210202","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3109\/08923979309035237","article-title":"In vivo effects of alprazolam and lorazepam on the immune response in patients with migraine without aura.","volume":"15","author":"Covelli","year":"1993","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"R291-11-20210202","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1128\/IAI.70.1.185-191.2002","article-title":"Deficient humoral responses underlie susceptibility to Toxoplasma gondii in CD4-deficient mice.","volume":"70","author":"Johnson","year":"2002","journal-title":"Infect Immun"},{"key":"R292-11-20210202","first-page":"11","article-title":"Quantitative and qualitative modifications of lymphocyte subsets after sublingual administration of isosorbide dinitrate in migraineurs. Preliminary report.","volume":"16","author":"Massari","year":"1994","journal-title":"Acta Neurol (Napoli)"},{"key":"R293-11-20210202","first-page":"721","article-title":"Immunoglobulin kappa\/lambda ratios in migraine and tension-type headache.","volume":"46","author":"Shimomura","year":"1992","journal-title":"Jpn J Psychiatry Neurol"},{"key":"R294-11-20210202","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1468-2982.1983.0302119.x","article-title":"Immunoglobulins and complement in migraine.","volume":"3","author":"Jerzmanowski","year":"1983","journal-title":"Cephalalgia"},{"key":"R295-11-20210202","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.4049\/jimmunol.156.9.3455","article-title":"A new biologic role for C3a and C3a desArg: regulation of TNF- and IL-1 synthesis.","volume":"156","author":"Takabayashi","year":"1996","journal-title":"J Immunol"},{"key":"R296-11-20210202","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1526-4610.2006.00337.x","article-title":"Pro-inflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally.","volume":"46","author":"Sarchielli","year":"2006","journal-title":"Headache"},{"key":"R297-11-20210202","first-page":"81","article-title":"Neurological damage mediated by cytokines.","volume":"14","author":"Munno","year":"1992","journal-title":"Acta Neurol (Napoli)"},{"key":"R298-11-20210202","first-page":"205","article-title":"Are TNF-alpha and IL-1 beta relevant in the pathogenesis of migraine without aura?","volume":"13","author":"Covelli","year":"1991","journal-title":"Acta Neurol (Napoli)"},{"key":"R299-11-20210202","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/00207459108986270","article-title":"Increased spontaneous release of tumor necrosis factor-alpha\/cachectin in headache patients. A possible correlation with plasma endotoxin and hypothalamic-pituitary-adrenal axis.","volume":"61","author":"Covelli","year":"1991","journal-title":"Int J Neurosci"},{"key":"R300-11-20210202","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jneuroim.2005.10.005","article-title":"The importance of cytokines, chemokines and nitric oxide in pathophysiology of migraine.","volume":"171","author":"Fidan","year":"2006","journal-title":"J Neuroimmunol"},{"key":"R301-11-20210202","first-page":"1276","article-title":"Pro-inflammatory cytokines in children with migraine with or without aura.","volume":"62","author":"Kacinski","year":"2005","journal-title":"Przegl Lek"},{"key":"R302-11-20210202","first-page":"1269","article-title":"Pro-inflammatory cytokines in children with idiopathic headache.","volume":"62","author":"Gergont","year":"2005","journal-title":"Przegl Lek"},{"key":"R304-11-20210202","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1111\/j.1526-4610.2005.00246.x","article-title":"Increased plasma transforming growth factor-beta 1 in migraine.","volume":"45","author":"Ishizaki","year":"2005","journal-title":"Headache"},{"key":"R305-11-20210202","first-page":"159","article-title":"Proinflammatory cytokines in cervicogenic headache.","volume":"14","author":"Martelletti","year":"1999","journal-title":"Funct Neurol"},{"key":"R306-11-20210202","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1046\/j.1526-4610.2002.02104.x","article-title":"Tumor necrosis factor gene polymorphism in migraine.","volume":"42","author":"Trabace","year":"2002","journal-title":"Headache"},{"key":"R307-11-20210202","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1526-4610.2002.02103.x","article-title":"A polymorphism in the interleukin-1 alpha gene influences the clinical features of migraine.","volume":"42","author":"Rainero","year":"2002","journal-title":"Headache"},{"key":"R308-11-20210202","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1526-4610.1991.hed3105310.x","article-title":"Decreased serum interleukin-2 level in patients with chronic headache.","volume":"31","author":"Shimomura","year":"1991","journal-title":"Headache"},{"key":"R309-11-20210202","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1128\/IAI.70.9.4757-4761.2002","article-title":"Susceptibility of interleukin-2-deficient mice to Toxoplasma gondii is associated with a defect in the production of gamma interferon.","volume":"70","author":"Villegas","year":"2002","journal-title":"Infection Immun"},{"key":"R310-11-20210202","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1046\/j.1526-4610.2001.01140.x","article-title":"Immunological aspects in migraine: increase of IL-10 plasma levels during attack.","volume":"41","author":"Munno","year":"2001","journal-title":"Headache"},{"key":"R311-11-20210202","first-page":"348","article-title":"Effects of cytokines and prolactin on the replication of Toxoplasma gondii in murine microglia.","volume":"12","author":"Benedetto","year":"2001","journal-title":"Eur Cytokine Netw"},{"key":"R312-11-20210202","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S1567-5769(02)00235-7","article-title":"Effects of histamine on Th1\/Th2 cytokine balance.","volume":"3","author":"Packard","year":"2003","journal-title":"Int Immunopharmacol"},{"key":"R313-11-20210202","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1128\/IAI.62.4.1392-1399.1994","article-title":"Immunological activities of Helicobacter pylori porins.","volume":"62","author":"Tufano","year":"1994","journal-title":"Infect Immun"},{"key":"R314-11-20210202","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3109\/00365529409096833","article-title":"Mucosal tumour necrosis factor-, interleukin-1b, and interleukin-8 production in patients with Helicobacter pylori infection.","volume":"29","author":"Noach","year":"1994","journal-title":"Scand J Gastroenterol"},{"key":"R315-11-20210202","first-page":"883","article-title":"Enhanced mucosal interleukin-6 and-8 in Helicobacter pylori-positive dyspeptic patients.","volume":"89","author":"Gionchetti","year":"1994","journal-title":"Am J Gastroenterol"},{"key":"R316-11-20210202","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/j.1365-2222.2004.01984.x","article-title":"Asymptomatic atopy is associated with increased indoleamine 2,3-dioxygenase activity and interleukin-10 production during seasonal allergen exposure.","volume":"34","author":"Von Bubnoff","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"R317-11-20210202","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.4049\/jimmunol.153.10.4583","article-title":"Enhancement of intracellular replication of Toxoplasma gondii by IL-6. Interactions with IFN-gamma and TNF-alpha.","volume":"153","author":"Beaman","year":"1994","journal-title":"J Immunol"},{"key":"R318-11-20210202","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/glia.20090","article-title":"Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons.","volume":"49","author":"Guillemin","year":"2005","journal-title":"Glia"},{"key":"R319-11-20210202","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/glia.10175","article-title":"Quinolinic acid up-regulates chemokine production and chemokine receptor expression in astrocytes.","volume":"41","author":"Guillemin","year":"2003","journal-title":"Glia"},{"key":"R320-11-20210202","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-4615-0135-0_12","article-title":"Expression of the kynurenine pathway enzymes in human microglia and macrophages.","volume":"527","author":"Guillemin","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"R321-11-20210202","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0165-5728(01)00418-0","article-title":"Synthesis and release of neurotoxic kynurenine metabolites by human monocyte-derived macrophages.","volume":"120","author":"Chiarugi","year":"2001","journal-title":"J Neuroimmunol"},{"key":"R322-11-20210202","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1046\/j.1471-4159.2002.00955.x","article-title":"Effects of systemic and central nervous system localized inflammation of the contributions of metabolic precursors to the L-kynurenine and quinolinic acid pools in brain.","volume":"82","author":"Kita","year":"2002","journal-title":"J Neurochem"},{"key":"R323-11-20210202","first-page":"213","article-title":"Nitric oxide precursor arginine and S-nitrosoglutathione in synaptic and glial function.","volume":"29","author":"Do","year":"1996","journal-title":"Neurochem Int"},{"key":"R324-11-20210202","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1023\/A:1007604414773","article-title":"NO synthase and NO-dependent signal pathways in brain aging and neurodegenerative disorders: the role of oxidant\/antioxidant balance.","volume":"25","author":"Calabrese","year":"2000","journal-title":"Neurochem Res"},{"key":"R325-11-20210202","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1046\/j.1468-2982.1998.1809631.x","article-title":"Level of nitric oxide-dependent cGMP in patients with migraine.","volume":"18","author":"Stepien","year":"1998","journal-title":"Cephalalgia"},{"key":"R326-11-20210202","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1600-0404.1996.tb07046.x","article-title":"L-Arginine\/nitric oxide pathway activation in platelets of migraine patients with and without aura.","volume":"94","author":"Gallai","year":"1996","journal-title":"Acta Neurol Scand"},{"key":"R327-11-20210202","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1468-2982.2002.00304.x","article-title":"Increased plasma nitrites in migraine and cluster headache patients in interictal period: basal hyperactivity of L-arginine-NO pathway?","volume":"22","author":"DAmico","year":"2002","journal-title":"Cephalalgia"},{"key":"R328-11-20210202","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1046\/j.1468-2982.2000.00146.x","article-title":"Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks.","volume":"20","author":"Sarchielli","year":"2000","journal-title":"Cephalalgia"},{"key":"R329-11-20210202","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1093\/brain\/123.9.1830","article-title":"Nitric oxide-induced headache in patients with chronic tension-type headache.","volume":"123","author":"Ashina","year":"2000","journal-title":"Brain"},{"key":"R330-11-20210202","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1517\/14656566.3.4.395","article-title":"Nitric oxide synthase inhibitors for the treatment of chronic tension-type headache.","volume":"3","author":"Ashina","year":"2002","journal-title":"Expert Opin Pharmacother"},{"key":"R331-11-20210202","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1212\/01.WNL.0000125188.79106.29","article-title":"Elevated levels of circulating trace amines in primary headaches.","volume":"62","author":"DAndrea","year":"2004","journal-title":"Neurology"},{"key":"R332-11-20210202","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF01248993","article-title":"Cardiovascular actions of kynuramine and 5-hydroxykynuramine in pithed rats.","volume":"57","author":"Charlton","year":"1988","journal-title":"J Neural Transm"},{"key":"R333-11-20210202","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1523\/JNEUROSCI.06-01-00094.1986","article-title":"Autoradiographic localization of tryptamine in the rat and dog CNS.","volume":"6","author":"McCormack","year":"1986","journal-title":"J Neurosci"},{"key":"R335-11-20210202","first-page":"17","article-title":"Kinetic properties of cloned human liver monoamine oxidase A.","volume":"41","author":"Ramsay","year":"1994","journal-title":"J Neural Transm"},{"key":"R336-11-20210202","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1007\/s00125-003-1219-0","article-title":"Nitric oxide generation mediated by beta-adrenoceptors is impaired in platelets from patients with type 2 diabetes mellitus.","volume":"46","author":"Queen","year":"2003","journal-title":"Diabetologia"},{"key":"R337-11-20210202","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1365-2249.1998.00499.x","article-title":"Human platelet inhibition of Toxoplasma gondii growth.","volume":"111","author":"Chumpitazi","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"R338-11-20210202","first-page":"15","article-title":"Role of IDO activities in anti-microbial defense in human native astrocytes. Adv Exp Med.","volume":"527","author":"Oberdorfer","year":"2003","journal-title":"Biol"},{"key":"R339-11-20210202","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0165-5728(93)90072-7","article-title":"Induction of toxoplasmosis in a human glioblastoma by interferon gamma.","volume":"43","author":"Daubener","year":"1993","journal-title":"J Neuroimmunol"},{"key":"R340-11-20210202","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1128\/IAI.72.5.2723-2730.2004","article-title":"Nitric-oxide-mediated regulation of gamma interferon-induced bacteriostasis: inhibition and degradation of human indoleamine 2,3-dioxygenase.","volume":"72","author":"Hucke","year":"2004","journal-title":"Infect Immun"},{"key":"R341-11-20210202","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/sj.cr.7290282","article-title":"Indoleamine 2,3-dioxygenase (IDO) is essential for dendritic cell activation and chemotactic responsiveness to chemokines.","volume":"15","author":"Hwang","year":"2005","journal-title":"Cell Res"},{"key":"R342-11-20210202","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF01345271","article-title":"Expression of the kynurenine enzymes in macrophages and microglial cells: regulation by immune modulators.","volume":"14","author":"Alberati-Giani","year":"1998","journal-title":"Amino Acids"},{"key":"R343-11-20210202","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1046\/j.1471-4159.1995.65031342.x","article-title":"Expression of inducible nitric oxide synthase in cerebral endothelial cells is regulated by cytokine-activated astrocytes.","volume":"65","author":"Borgerding","year":"1995","journal-title":"J Neurochem"},{"key":"R344-11-20210202","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0006-8993(01)02346-0","article-title":"Combination of inflammatory cytokines increases nitrite and nitrate levels in the paraventricular nucleus of conscious rats.","volume":"905","author":"Wakita","year":"2001","journal-title":"Brain Res"},{"key":"R345-11-20210202","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1128\/IAI.70.2.779-786.2002","article-title":"Tryptophan-L-kynurenine pathway metabolism accelerated by Toxoplasma gondii infection is abolished in gamma interferon-deficient mice: cross-regulation between inducible nitric oxide synthase and indoleamine 2,3-dioxygenase.","volume":"70","author":"Fujigaki","year":"2002","journal-title":"Infect Immun"},{"key":"R346-11-20210202","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1468-2982.2005.00916.x","article-title":"Platelet activation and platelet-leucocyte interaction in patients with migraine. Subtype differences and influence of triptans.","volume":"25","author":"Zeller","year":"2005","journal-title":"Cephalalgia"},{"key":"R347-11-20210202","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0022-510X(02)00035-7","article-title":"L-Arginine\/nitric oxide pathway in chronic tension-type headache: relation with serotonin content and secretion and glutamate content.","volume":"198","author":"Sarchielli","year":"2002","journal-title":"J Neurol Sci"},{"key":"R348-11-20210202","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1526-4610.1993.hed3310528.x","article-title":"Platelet substance P and 5-hydroxytryptamine in migraine and tension-type headache.","volume":"33","author":"Nakano","year":"1993","journal-title":"Headache"},{"key":"R349-11-20210202","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1468-2982.2004.00863.x","article-title":"Platelet membrane fluidity and peroxinitrate levels in migraine patients during headache-free periods.","volume":"25","author":"Taffi","year":"2005","journal-title":"Cephalalgia"},{"key":"R350-11-20210202","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1526-4610.1994.hed3409515.x","article-title":"Increased 11-dehydrothromboxane B2 in migraine: platelet hyperfunction in patients with migraine during headache-free period.","volume":"34","author":"Kitano","year":"1994","journal-title":"Headache"},{"key":"R351-11-20210202","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1468-2982.2003.00717.x","article-title":"Platelet-activating factor (PAF) in internal jugular venous blood of migraine without aura patients assessed during migraine attacks.","volume":"24","author":"Sarchielli","year":"2004","journal-title":"Cephalalgia"},{"key":"R352-11-20210202","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00024382-200304000-00008","article-title":"Platelet-activating factor synthesis by neutrophils, monocytes, and endothelial cells is modulated by nitric oxide production.","volume":"19","author":"Mariano","year":"2003","journal-title":"Shock"},{"key":"R353-11-20210202","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/135502801300069692","article-title":"Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and Tat.","volume":"7","author":"Smith","year":"2001","journal-title":"J Neurovirol"},{"key":"R354-11-20210202","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1023\/A:1016146305000","article-title":"Influence of platelet-activating factor, its cell analogs and antagonist on the production of superoxide radicals by blood leukocytes of healthy and hypercholesterolemic individuals.","volume":"67","author":"Kulikov","year":"2002","journal-title":"Biochemistry (Mosc)"},{"key":"R356-11-20210202","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jnr.10373","article-title":"Neuroprotective E2 or cAMP against microglial and neuronal free radical mediated toxicity associated with inflammation.","volume":"70","author":"Kim","year":"2002","journal-title":"J Neurosci Res"},{"key":"R357-11-20210202","first-page":"4822","article-title":"Differential infectivity and division of Toxoplasma gondii in human peripheral blood leukocytes. Infect.","volume":"68","author":"Channon","year":"2000","journal-title":"Immun"},{"key":"R358-11-20210202","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1600-065X.1980.tb01042.x","article-title":"Dendritic cells: features and functions.","volume":"53","author":"Steinman","year":"1980","journal-title":"Immunol Rev"},{"key":"R359-11-20210202","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/0006-8993(87)90311-8","article-title":"Melatonin, 5-hydroxytryptamine and some of their analogues as cyclo-oxygenase inhibitors in rat medial basal hypothalamus.","volume":"405","author":"Franchi","year":"1987","journal-title":"Brain Res"},{"key":"R360-11-20210202","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0006-291X(84)90732-0","article-title":"N-acetyl-5-methoxykynuramine, a brain metabolite of melatonin, is a potent inhibitor of prostaglandin biosynthesis.","volume":"121","author":"Kelly","year":"1984","journal-title":"Biochem Biophys Res Commun"},{"key":"R361-11-20210202","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1100\/tsw.2002.808","article-title":"Calcitonin gene-related peptide in tension-type headache.","volume":"2","author":"Ashina","year":"2002","journal-title":"Sci World J"},{"key":"R362-11-20210202","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1212\/WNL.55.9.1335","article-title":"Plasma levels of calcitonin gene-related peptide in chronic tension-type headache.","volume":"55","author":"Ashina","year":"2000","journal-title":"Neurology"},{"key":"R363-11-20210202","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0197-0186(01)00094-8","article-title":"Substance P and calcitonin gene-related peptide increase IL-1 beta, IL-6 and TNF alpha secretion from human peripheral blood mononuclear cells.","volume":"40","author":"Cuesta","year":"2002","journal-title":"Neurochem Int"},{"key":"R364-11-20210202","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1046\/j.1468-2982.1998.1806329.x","article-title":"Endothelin in migraine patients.","volume":"18","author":"Kallela","year":"1998","journal-title":"Cephalalgia"},{"key":"R365-11-20210202","doi-asserted-by":"crossref","first-page":"H1868","DOI":"10.1152\/ajpheart.00241.2004","article-title":"Prevention of endothelin-1-induced increases in blood pressure: role of endogenous CGRP.","volume":"287","author":"Wang","year":"2004","journal-title":"Am J Physiol Circ Physiol"},{"key":"R366-11-20210202","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1161\/01.HYP.29.1.65","article-title":"Endothelin-1 inhibits nitric oxide synthesis in vascular smooth muscle cells.","volume":"29","author":"Ikeda","year":"1997","journal-title":"Hypertension"},{"key":"R367-11-20210202","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1212\/WNL.57.1.132","article-title":"Levels of nerve growth factor in cerebrospinal fluid of chronic daily headache patients.","volume":"57","author":"Sarchielli","year":"2001","journal-title":"Neurology"},{"key":"R368-11-20210202","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1586\/14737175.4.1.115","article-title":"Nerve growth factor and chronic daily headache: a potential implication for therapy.","volume":"4","author":"Sarchielli","year":"2004","journal-title":"Expert Rev Neurother"},{"key":"R369-11-20210202","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1468-2982.2003.00552.x","article-title":"Glutamate and nitric oxide pathway in chronic daily headache: evidence from cerebrospinal fluid.","volume":"23","author":"Gallai","year":"2003","journal-title":"Cephalalgia"},{"key":"R370-11-20210202","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/j.1526-4610.2005.00263.x","article-title":"Serum S100 protein in children with acute recurrent headache: a potentially useful marker for migraine.","volume":"45","author":"Papandreou","year":"2005","journal-title":"Headache"},{"key":"R372-11-20210202","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1203\/01.PDR.0000169999.66157.C0","article-title":"Acute hypoxia increases S100 protein in association with blood flow redistribution away from peripheral circulation in fetal sheep.","volume":"58","author":"Giussani Da, Thakor","year":"2005","journal-title":"Pediatr Res"},{"key":"R373-11-20210202","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jneuroim.2004.05.007","article-title":"Involvement of substance P, CGRP and histamine in the hyperalgesia and cytokine upregulation induced by intraplantar injection of capsaicin in rats.","volume":"153","author":"Massaad","year":"2004","journal-title":"J Neuroimmunol"},{"key":"R374-11-20210202","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1113\/jphysiol.1990.sp018288","article-title":"Competitive antagonists and partial agonists at the glycine modulatory site of the mouse NMDA receptors.","volume":"430","author":"Henderson","year":"1990","journal-title":"J Physiol"},{"key":"R375-11-20210202","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0014-2999(88)90367-6","article-title":"Kynurenic acid antagonises responses to NMDA via an action at the strychnine-insensitive glycine receptor.","volume":"154","author":"Birch","year":"1988","journal-title":"Eur J Pharmacol"},{"key":"R376-11-20210202","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1046\/j.0953-816x.2001.01592.x","article-title":"Presynaptic kynrenate-sensitive receptors inhibit glutamate release.","volume":"13","author":"Carpenedo","year":"2001","journal-title":"Eur J Neurosci"},{"key":"R377-11-20210202","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0014-2999(81)90587-2","article-title":"Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS.","volume":"72","author":"Stone","year":"1981","journal-title":"Eur J Pharmacol"},{"key":"R378-11-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00702-002-0770-z","article-title":"Kynurenate production by cultured human astrocytes.","volume":"110","author":"Kiss","year":"2003","journal-title":"J Neural Transm"},{"key":"R379-11-20210202","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1046\/j.1526-4610.1997.3709561.x","article-title":"Platelet ionized magnesium, cyclic AMP, and cyclic GMP levels in migraine and tension-type headache.","volume":"37","author":"Mishima","year":"1997","journal-title":"Headache"},{"key":"R380-11-20210202","first-page":"109","article-title":"Headache due to photosensitive magnesium depletion.","volume":"18","author":"Durlach","year":"2005","journal-title":"Magnes Res"},{"key":"R382-11-20210202","doi-asserted-by":"crossref","first-page":"7266","DOI":"10.1021\/bi992997s","article-title":"3-Hydroxykynurenine and 3-hydroxyanthranilic acid generate hydrogen peroxide and promote -crystallin cross-linking by metal ion reduction.","volume":"39","author":"Goldstein","year":"2000","journal-title":"Biochemistry"},{"key":"R383-11-20210202","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1046\/j.1365-2826.1998.00203.x","article-title":"Modification of nitric oxide synthase activity and neuronal response in rat striatum by melatonin and kynurenine derivatives.","volume":"10","author":"Leon","year":"1998","journal-title":"J Neuroendocrinol"},{"key":"R384-11-20210202","first-page":"141","article-title":"Acute recurrent headaches: clinical and epidemiological characteristics.","volume":"62","author":"Dura","year":"2005","journal-title":"Ann Pediatr (Barc)"},{"key":"R385-11-20210202","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.2174\/1381612053381693","article-title":"Estrogen and cytokines production-the possible cause of gender differences in neurological diseases.","volume":"11","author":"Czlonkowska","year":"2005","journal-title":"Curr Pharm Des"},{"key":"R386-11-20210202","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1128\/IAI.63.7.2549-2555.1995","article-title":"Sex-determined resistance to Toxoplasma gondii is associated with temporal differences in cytokine production.","volume":"63","author":"Roberts","year":"1995","journal-title":"Infect Immun"},{"key":"R387-11-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-308X(08)60020-2","article-title":"Parasitic infections in women and their consequences.","volume":"31","author":"Brabin","year":"1992","journal-title":"Adv Parasitol"},{"key":"R388-11-20210202","first-page":"67","article-title":"A histological and immunohistochemical study of the changes induced in the brains of white mice by infection with Toxoplasma gondii.","volume":"65","author":"Kittas","year":"1984","journal-title":"Br J Exp Pathol"},{"key":"R389-11-20210202","first-page":"704","article-title":"Cellular immune responses to recombinant antigens in pregnant women chronically infected with Toxoplasma gondii.","volume":"9","author":"Fatoohi","year":"2002","journal-title":"Clin Diagn Lab Immun"},{"key":"R390-11-20210202","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1002\/eji.1830220921","article-title":"Kinetics of cytokine mRNA in the brains of mice with progressive toxoplasmic encephalitis.","volume":"22","author":"Hunter","year":"1992","journal-title":"Eur J Immunol"},{"key":"R391-11-20210202","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4049\/jimmunol.146.1.286","article-title":"Synergistic role of CD4+ and CD8+ lymphocytes in IFN- production and protective immunity induced by an attenuated Toxoplasma gondii vaccine.","volume":"146","author":"Gazzinelli","year":"1991","journal-title":"J Immunol"},{"key":"R392-11-20210202","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.4049\/jimmunol.131.6.2767","article-title":"Sex steroid receptors in peripheral T cells: absence of androgen receptors and restriction of estrogen receptors to OKT8-positive cells.","volume":"131","author":"Cohen","year":"1983","journal-title":"J Immunol"},{"key":"R393-11-20210202","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000293766","article-title":"NK cell activity and estrogen levels during normal human pregnancy.","volume":"25","author":"Gabrilovac","year":"1988","journal-title":"Gynecol Obstet Invest"},{"key":"R394-11-20210202","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0165-2478(93)90065-A","article-title":"Enhancing effect of 17 beta-estradiol on human NK cell activity.","volume":"1","author":"Sorachi","year":"1993","journal-title":"Immunol Lett"},{"key":"R395-11-20210202","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3109\/00207459008999730","article-title":"The influence of beta-estradiol and progesterone on interferon gamma production in vitro.","volume":"51","author":"Grasso","year":"1990","journal-title":"Int J Neurosci"},{"key":"R396-11-20210202","doi-asserted-by":"crossref","first-page":"6391","DOI":"10.4049\/jimmunol.174.10.6391","article-title":"Estradiol is required for a proper immune response to bacterial and viral pathogens in the female brain.","volume":"174","author":"Soucy","year":"2005","journal-title":"J Immunol"},{"key":"R397-11-20210202","first-page":"2403","article-title":"Estrogen modulates the hypothalamic-pituitary-adrenal and inflammatory cytokine responses to endotoxin in women.","volume":"86","author":"Puder","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R398-11-20210202","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/jwh.2005.14.19","article-title":"Sex and racial differences in pharmacological response: where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics.","volume":"14","author":"Anderson","year":"2005","journal-title":"J Womens Health"},{"key":"R399-11-20210202","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1152\/ajpendo.00513.2001","article-title":"Growth hormone secretion is an independent regulator of growth hormone actions in humans.","volume":"283","author":"Jaffe","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R400-11-20210202","first-page":"254","article-title":"Important role of proinflammatory cytokines\/other endogenous substances in drug-induced hepatotoxicity: depression of drug metabolism during infections\/inflammation states, and genetic polymorphisms of drug-metabolizing enzymes\/cytokines may markedly contribute to this pathology.","volume":"12","author":"Prandota","year":"2005","journal-title":"Am J Ther"},{"key":"R401-11-20210202","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.brainres.2004.09.031","article-title":"Nitric oxide mediates and LPS-induced depression of cytochrome P450 (CYP1A) activity in astrocytes.","volume":"1029","author":"Nicholson","year":"2004","journal-title":"Brain Res"},{"key":"R402-11-20210202","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/S0161-6420(99)90266-X","article-title":"Pseudotumor cerebri in children receiving recombinant human growth hormone.","volume":"106","author":"Rogers","year":"1999","journal-title":"Ophthalmology"},{"key":"R403-11-20210202","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0022-3565(24)37278-7","article-title":"Human hepatocyte growth factor down-regulates the expression of cytochrome P-450 isoenzymes in human hepatocytes n primary culture.","volume":"284","author":"Donato","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"R404-11-20210202","first-page":"207","article-title":"Regulation of cytochrome P450 by inflammatory mediators: why and how?","volume":"29","author":"Morgan","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"R405-11-20210202","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/00045391-200303000-00012","article-title":"Overview of existing research and information linking isotretinoin (accutane), depression, psychosis, and suicide.","volume":"10","author":"ODonnell","year":"2003","journal-title":"Am J Ther"},{"key":"R406-11-20210202","first-page":"1334","article-title":"Lithium interaction with the cyclooxygenase 2 inhibitors rofecoxib and celecoxib and other nonsteroidal antiinflammatory drugs.","volume":"1328-","author":"Phelan","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"R407-11-20210202","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0733-8619(03)00096-3","article-title":"Pseudotumor cerebri.","volume":"22","author":"Friedman","year":"2004","journal-title":"Neurol Clin"},{"key":"R408-11-20210202","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/adc.2004.067256","article-title":"Serious neurological disorders in children with chronic headache.","volume":"90","author":"Abu-Arafeh","year":"2005","journal-title":"Arch Dis Child"},{"key":"R409-11-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-244X-4-1","article-title":"Toxoplasma seropositivity and depression: a case report.","volume":"4","author":"Kar","year":"2004","journal-title":"BMC Psychiatry"},{"key":"R410-11-20210202","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s007870170027","article-title":"Obsessive-compulsive disorder and acquired toxoplasmosis in two children.","volume":"10","author":"Brynska","year":"2001","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"R411-11-20210202","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1086\/319221","article-title":"Antibodies to toxoplasma gondii in individuals with first-episode schizophrenia.","volume":"32","author":"Yolken","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R412-11-20210202","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1471-244X-4-32","article-title":"Toxoplasma and coxiella infection and psychiatric morbidity: a retrospective cohort analysis.","volume":"4","author":"Thomas","year":"2004","journal-title":"BMC Psychiatry"},{"key":"R413-11-20210202","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/sj.mp.4001600","article-title":"IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity.","volume":"10","author":"Wichers","year":"2005","journal-title":"Mol Psychiatry"},{"key":"R414-11-20210202","first-page":"11","article-title":"The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression.","volume":"29","author":"Wichers","year":"2004","journal-title":"J Psychiatry Neurosci"},{"key":"R415-11-20210202","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1006\/bbrc.1993.1380","article-title":"Particular ability of liver P450s3A to catalyze the oxidation of N-omega-hydroxyarginine to citrulline and nitrogen oxides and occurrence in NO synthases of a sequence very similar to the heme-binding sequence in P450s.","volume":"192","author":"Renaud","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"R416-11-20210202","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/(SICI)1096-9861(19960304)366:2<244::AID-CNE5>3.0.CO;2-5","article-title":"Regional distribution of cytochrome P450 2D1 in the rat central nervous system.","volume":"366","author":"Norris","year":"1996","journal-title":"J Comp Neurol"},{"key":"R417-11-20210202","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1124\/dmd.30.1.42","article-title":"The role of cytokines in the depression of CYP1A activity using cultured astrocytes as an in vitro model of inflammation in the central nervous system.","volume":"30","author":"Nicholson","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"R418-11-20210202","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1126\/science.2422758","article-title":"Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor.","volume":"232","author":"Majewska","year":"1986","journal-title":"Science (Washington DC)"},{"key":"R419-11-20210202","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000159228","article-title":"Cytochrome P450 metabolites of arachidonic acid as intracellular signalling molecules in vascular tissue.","volume":"34","author":"Harder","year":"1997","journal-title":"J Vasc Res"},{"key":"R420-11-20210202","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/B978-0-12-185292-4.50010-3","article-title":"Cytochrome P450 enzymes in brain.","volume":"22","author":"Warner","year":"1994","journal-title":"Meth Neurosci"},{"key":"R421-11-20210202","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/0003-9861(87)90142-1","article-title":"Brain mitochondrial cytochrome P-450scc: spectral and catalytic properties.","volume":"254","author":"Walther","year":"1987","journal-title":"Arch Biochem Biophys"},{"key":"R422-11-20210202","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/S0006-2952(00)00281-1","article-title":"Regional and cellular induction of nicotine-metabolizing CYP2B1 in rat brain by chronic nicotine treatment.","volume":"59","author":"Miksys","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"R423-11-20210202","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/0378-4274(95)03509-5","article-title":"Expression of multiple forms of brain cytochrome P450.","volume":"82-","author":"Strobel","year":"1995","journal-title":"Toxicol Lett"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00045391-200701000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T20:43:31Z","timestamp":1736801011000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045391-200701000-00011"}},"subtitle":["The Parasite May Be Responsible for the Neurogenic Inflammation Postulated as a Cause of Different Types of Headaches"],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":400,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/01.mjt.0000208272.42379.aa","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}